<table id="inv-70a44830-3d6b-4f5f-92ce-9cd7a884a683" width="NaN" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<col width="NaN%"></col>
<col width="NaN%"></col>
<col width="NaN%"></col>
<tbody>
<tr id="id_b69dbaa0-be4e-454b-819e-fe1ec3c319d0">
<td align="center" colspan="3" stylecode="Botrule" valign="top">
<content stylecode="bold">Table II. Mean and range
                                                  of total body clearance and half-life of
                                                  theophylline related to age and altered
                                                  physiological states.</content>
<footnote id="inv-2a8fbd63-9e27-4c83-b2ed-252772058daa">For
                                                  various North American patient populations from
                                                  literature reports. Different rates of elimination
                                                  and consequent dosage requirements have been
                                                  observed among other peoples.</footnote>
</td>
</tr>
<tr id="id_76ddcac6-752c-4bc3-9aa6-7d2437b91eb7">
<td align="center" stylecode="Botrule" valign="bottom">
<content stylecode="bold">Population
                                                  characteristics</content>
</td>
<td align="center" stylecode="Botrule" valign="bottom">
<content stylecode="bold">Total body
                                                  clearance<footnote id="inv-8b93c772-e8a8-4024-96d8-78c38d332b18">Clearance represents the volume of blood
                                                  completely cleared of theophylline by the liver in
                                                  one minute. Values listed were generally
                                                  determined at serum theophylline concentrations
                                                  &lt;20 mcg/mL; clearance may decrease and
                                                  half-life may increase at higher serum
                                                  concentrations due to non-linear
                                                  pharmacokinetics.</footnote> mean (range)<footnote id="inv-6cd7823c-231f-475a-9688-8a0493f66669">Reported range or estimated range (mean Â± 2 SD)
                                                  where actual range not reported.</footnote>
<br/>
                                                  (mL/kg/min)</content>
</td>
<td align="center" stylecode="Botrule" valign="bottom">
<content stylecode="bold">Half-life<br/> mean
                                                  (range)<footnoteref idref="inv-6cd7823c-231f-475a-9688-8a0493f66669"></footnoteref>
<br/> (hr)</content>
</td>
</tr>
<tr id="id_0d303e18-192e-4c99-92ba-1e6ee49a0666">
<td align="left" colspan="3" valign="top">
<content stylecode="underline">Age</content>
</td>
</tr>
<tr id="id_b03d4fa9-7812-4db9-ac38-7e91caf3983b">
<td align="left" valign="top">Premature
                                                  neonates</td>
<td align="left" valign="top"></td>
<td align="left" valign="top"></td>
</tr>
<tr id="id_4f7f9dbb-e08a-4561-9bc5-b5483664d1e2">
<td align="left" valign="top">postnatal age 3-15
                                                  days</td>
<td align="left" valign="top">0.29
                                                  (0.09-0.49)</td>
<td align="left" valign="top">30 (17-43)</td>
</tr>
<tr id="id_69323b0c-8056-48d1-8cac-b7b0a56e1238">
<td align="left" valign="top">postnatal age 25-57
                                                  days</td>
<td align="left" valign="top">0.64 (0.04-1.2)</td>
<td align="left" valign="top">20 (9.4 -30.6)</td>
</tr>
<tr id="id_e686f418-cea3-4bc0-821b-f39a6cc594d0">
<td align="left" colspan="3" valign="top">Term
                                                  infants</td>
</tr>
<tr id="id_5fb4bb6f-e9a4-4665-aff0-464ea9b19c96">
<td align="left" valign="top">postnatal age 1-2
                                                  days</td>
<td align="left" valign="top">NR<footnote id="inv-04ac1eb1-ae3a-40a3-b4c4-0725534f547d">NR =
                                                  not reported or not reported in a comparable
                                                  format.</footnote>
</td>
<td align="left" valign="top">25.7 (25-26.5)</td>
</tr>
<tr id="id_65754eff-4b6b-4ccd-a7e6-971c47f367d4">
<td align="left" valign="top">postnatal age 3-30
                                                  weeks</td>
<td align="left" valign="top">NR<footnoteref idref="inv-04ac1eb1-ae3a-40a3-b4c4-0725534f547d"></footnoteref>
</td>
<td align="left" valign="top">11 (6-29)</td>
</tr>
<tr id="id_a447e7f4-c2ff-464e-9e76-32551441f730">
<td align="left" colspan="3" valign="top">Children</td>
</tr>
<tr id="id_5a8e4078-346f-4ce8-a75d-94878ed40a9a">
<td align="left" valign="top">1-4 years</td>
<td align="left" valign="top">1.7 (0.5-2.9)</td>
<td align="left" valign="top">3.4 (1.2-5.6)</td>
</tr>
<tr id="id_40a0436e-07b8-409d-be79-7d95219485f6">
<td align="left" valign="top">4-12 years</td>
<td align="left" valign="top">1.6 (0.8-2.4)</td>
<td align="left" valign="top">NR<footnoteref idref="inv-04ac1eb1-ae3a-40a3-b4c4-0725534f547d"></footnoteref>
</td>
</tr>
<tr id="id_be224342-c956-4e19-bba6-03dbc53fbf47">
<td align="left" valign="top">13-15 years</td>
<td align="left" valign="top">0.9 (0.48-1.3)</td>
<td align="left" valign="top">NR<footnoteref idref="inv-04ac1eb1-ae3a-40a3-b4c4-0725534f547d"></footnoteref>
</td>
</tr>
<tr id="id_1da53e4a-4ac1-42ef-a569-2cd40ddec4b4">
<td align="left" valign="top">6-17 years</td>
<td align="left" valign="top">1.4 (0.2-2.6)</td>
<td align="left" valign="top">3.7 (1.5-5.9)</td>
</tr>
<tr id="id_22774f79-6df8-43c4-b6ee-d30cc2d9c4f2">
<td align="left" colspan="3" valign="top">Adults
                                                  (16-60 years)</td>
</tr>
<tr id="id_cc01fb98-9507-4fa6-8817-d840933bd1f2">
<td align="left" valign="top">otherwise
                                                  healthy</td>
<td align="left" valign="top"></td>
<td align="left" valign="top"></td>
</tr>
<tr id="id_dd3c528c-52ed-416f-b102-eae3f4c9e963">
<td align="left" valign="top">nonsmoking
                                                  asthmatics</td>
<td align="left" valign="top">0.65
                                                  (0.27-1.03)</td>
<td align="left" valign="top">8.7 (6.1-12.8)</td>
</tr>
<tr id="id_02d1fabf-d4ee-4277-ae92-7ce18dcc1a06">
<td align="left" colspan="3" valign="top">Elderly
                                                  (&gt;60 years)</td>
</tr>
<tr id="id_5f684a3d-f410-4833-b8f7-c348d482efe6">
<td align="left" valign="top">nonsmokers with
                                                  normal cardiac, liver, and renal function</td>
<td align="left" valign="top">0.41
                                                  (0.21-0.61)</td>
<td align="left" valign="top">9.8 (1.6-18)</td>
</tr>
<tr id="id_4e8a5d2c-e302-4719-bd6d-85f71ca3b933">
<td align="left" colspan="3" valign="top">Concurrent illness or<br/>
<content stylecode="underline">altered physiological
                                                  state</content>
</td>
</tr>
<tr id="id_fb847ceb-1134-4507-83ff-f3cc045668f9">
<td align="left" valign="top">Acute pulmonary
                                                  edema</td>
<td align="left" valign="top">0.33<footnote id="inv-a0b822cf-8b2b-4a13-ad8b-8d15f935d50a">Median<br/>
<content stylecode="underline">
<content stylecode="bold">Note</content>
</content>: In addition to the factors listed
                                                  above, theophylline clearance is increased and
                                                  half-life decreased by low carbohydrate/high
                                                  protein diets, parenteral nutrition, and daily
                                                  consumption of charcoal-broiled beef. A high
                                                  carbohydrate/low protein diet can decrease the
                                                  clearance and prolong the half-life of
                                                  theophylline.</footnote> (0.07-2.45)</td>
<td align="left" valign="top">19<footnoteref idref="inv-a0b822cf-8b2b-4a13-ad8b-8d15f935d50a"></footnoteref>
                                                  (3.1-82)</td>
</tr>
<tr id="id_7075ae04-e5d3-4c55-9be5-ac92450b45d1">
<td align="left" valign="top">COPD-&gt;60
                                                  years, stable</td>
<td align="left" valign="top"></td>
<td align="left" valign="top"></td>
</tr>
<tr id="id_d75a0043-6e4d-4567-86d6-db948b6df03e">
<td align="left" valign="top">nonsmoker &gt;1
                                                  year</td>
<td align="left" valign="top">0.54
                                                  (0.44-0.64)</td>
<td align="left" valign="top">11 (9.4- 12.6)</td>
</tr>
<tr id="id_4ded314c-85e1-4d99-96c4-4952649d32c8">
<td align="left" valign="top">COPD with cor
                                                  pulmonale</td>
<td align="left" valign="top">0.48
                                                  (0.08-0.88)</td>
<td align="left" valign="top">NR<footnoteref idref="inv-04ac1eb1-ae3a-40a3-b4c4-0725534f547d"></footnoteref>
</td>
</tr>
<tr id="id_45b7ce0f-5ee6-49e2-a9d2-52ba6e2bf8a5">
<td align="left" valign="top">Cystic fibrosis
                                                  (14-28 years)</td>
<td align="left" valign="top">1.25 (0.31-2.2)</td>
<td align="left" valign="top">6.0 (1.8-10.2)</td>
</tr>
<tr id="id_215e78f5-03ac-4c10-aac3-eb78e1a87a51">
<td align="left" valign="top">Fever associated
                                                  with acute viral respiratory illness (children
                                                  9-15 years)</td>
<td align="left" valign="top">NR<footnoteref idref="inv-04ac1eb1-ae3a-40a3-b4c4-0725534f547d"></footnoteref>
</td>
<td align="left" valign="top">7.0 (1.0-13)</td>
</tr>
<tr id="id_d4ce083d-3e95-4788-91ac-c3e66977b750">
<td align="left" colspan="3" valign="top">Liver
                                                  disease -</td>
</tr>
<tr id="id_64502018-e576-4edb-9ea9-38f9e44b9235">
<td align="left" valign="top">cirrhosis</td>
<td align="left" valign="top">0.31<footnoteref idref="inv-a0b822cf-8b2b-4a13-ad8b-8d15f935d50a"></footnoteref>
                                                  (0.1-0.7)</td>
<td align="left" valign="top">32<footnoteref idref="inv-a0b822cf-8b2b-4a13-ad8b-8d15f935d50a"></footnoteref>
                                                  (10-56)</td>
</tr>
<tr id="id_29d02c38-3233-4b3c-a722-a6b2a24fb65a">
<td align="left" valign="top">acute hepatitis</td>
<td align="left" valign="top">0.35
                                                  (0.25-0.45)</td>
<td align="left" valign="top">19.2
                                                  (16.6-21.8)</td>
</tr>
<tr id="id_6c8674ec-884b-4ab0-819d-a0eb4986f0f4">
<td align="left" valign="top">cholestasis</td>
<td align="left" valign="top">0.65
                                                  (0.25-1.45)</td>
<td align="left" valign="top">14.4 (5.7-31.8)</td>
</tr>
<tr id="id_02c74f8c-c7ec-4ace-9e78-795812e736fe">
<td align="left" colspan="3" valign="top">Pregnancy -</td>
</tr>
<tr id="id_4bc6339c-1216-423c-a8f8-0f1d6228c3ad">
<td align="left" valign="top">1st trimester</td>
<td align="left" valign="top">NR<footnoteref idref="inv-04ac1eb1-ae3a-40a3-b4c4-0725534f547d"></footnoteref>
</td>
<td align="left" valign="top">8.5 (3.1-13.9)</td>
</tr>
<tr id="id_35c84230-519d-4c95-8bc8-e70e162a8b2b">
<td align="left" valign="top">2nd trimester</td>
<td align="left" valign="top">NR<footnoteref idref="inv-04ac1eb1-ae3a-40a3-b4c4-0725534f547d"></footnoteref>
</td>
<td align="left" valign="top">8.8 (3.8-13.8)</td>
</tr>
<tr id="id_79dc9c7e-ee9f-49ce-bd9f-41d9a6c9216b">
<td align="left" valign="top">3rd trimester</td>
<td align="left" valign="top">NR<footnoteref idref="inv-04ac1eb1-ae3a-40a3-b4c4-0725534f547d"></footnoteref>
</td>
<td align="left" valign="top">13.0 (8.4-17.6)</td>
</tr>
<tr id="id_6984c54c-a19a-4d0a-a2b5-d57cc63aed71">
<td align="left" valign="top">Sepsis with
                                                  multi-organ failure</td>
<td align="left" valign="top">0.47 (0.19-1.9)</td>
<td align="left" valign="top">18.8 (6.3-24.1)</td>
</tr>
<tr id="id_75c543c6-ab9a-45a5-950d-e651a6264f3b">
<td align="left" colspan="3" valign="top">Thyroid
                                                  disease -</td>
</tr>
<tr id="id_78879f3b-59e4-4970-ab11-bd9a6c08aaa3">
<td align="left" valign="top">hypothyroid</td>
<td align="left" valign="top">0.38
                                                  (0.13-0.57)</td>
<td align="left" valign="top">11.6 (8.2-25)</td>
</tr>
<tr id="id_77ef1c28-874a-4c3c-b508-01f8916363ca">
<td align="left" valign="top">hyperthyroid</td>
<td align="left" valign="top">0.8 (0.68-0.97)</td>
<td align="left" valign="top">4.5 (3.7-5.6)</td>
</tr>
</tbody>
</table>